B/T cell crosstalk and aberrant inflammatory IgG exacerbate autoimmune intestinal inflammation
I. Gadjalova, J. M. Heinze, M. C. Goess, J. Hofmann, J. J. Albers, R. Spallek, B. Blissenbach, A. Buck, M.-C. Weber, E. Scherer, M. Kampick, R. Oellinger, O. Krut, R. Rad, K. Steiger, C. Winter, K.-P. Janssen, P.-A. Neumann, R. S. Geha, J. Ruland, S. J. Keppler
Abstract
Dysregulated B cell responses have been described in inflammatory-bowel disease (IBD) patients; however, the role of B cells in IBD pathology remained incompletely understood. We here described Wiskott-Aldrich Syndrome interacting protein deficient (Wipf1-/-) mice as novel mouse model of spontaneous, chronic colitis modelling human IBD. Concomitant with aberrant IgG production in colonic tissue of Wipf1-/- mice, we identified systemic, hypo-sialylated IgG as drivers of IL-1{beta} production in monocytes. Pathological antibody production was promoted by the hyper-reactivity of Wipf1-/- B cells in response to LPS stimulation, resulting in efficient activation of the MAPK/Erk and mTOR/Akt/4E-BP1 pathways and heightened metabolic activity. In addition to abundant inflammatory IgG, we found that B cells directly promoted the production of pro-inflammatory cytokines by intestinal CD4+ T cells. B/T co-culture assays defined the co-stimulatory molecule CD86 as driver of IFN-{gamma} and GM-CSF production by CD4+ T cells. CD86 expression was further enhanced by the presence of sCD40L, which was elevated in sera of Wipf1-/- mice. Similarly, colonic B cells of IBD patients expressed increased mRNA levels of CD86 correlating with enhanced levels of systemic sCD40L. Together, B cell-mediated pro-inflammatory cytokine secretion and B cell-derived inflammatory antibody production contributed to exacerbated pathogenesis during intestinal inflammation. O_FIG O_LINKSMALLFIG WIDTH=168 HEIGHT=200 SRC="FIGDIR/small/507066v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@1449ae8org.highwire.dtl.DTLVardef@116045borg.highwire.dtl.DTLVardef@77f3f2org.highwire.dtl.DTLVardef@130a271_HPS_FORMAT_FIGEXP M_FIG C_FIG One Sentence SummaryB cells fuel intestinal inflammation
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- IL-36/IL-36R Signaling Promotes CD4+ T Cell-Dependent Colitis via Pro-Inflammatory Cytokine Production
M. Maarouf, M. Kuczma, T. L. Denning·bioRxiv·May 24, 2023
- Type I interferon signaling promotes mucosal inflammation in murine models of colitis
Jianyi Yin, Rodrigo Galicia-Pereyra, … Ezra Burstein·bioRxiv·Mar 4, 2026
- BUTYRATE AMELIORATES INFLAMMATION IN COLON BIOPSY SAMPLES OF IBD PATIENTS AND EXPERIMENTAL COLITIS IN MICE INVOLVING RNA BINDING PROTEIN, AUF1-IL-27 AXIS AND ACCELERATING B1a TO B10 POLARIZATION
Aaheli Masid, Oishika Das, … Moumita Bhaumik·bioRxiv·May 24, 2024
- DNAM-1 immunoreceptor integrates innate and adaptive immune programs to drive intestinal inflammation
Natsuki Ide, kazuki Sato, … Akira Shibuya·bioRxiv·Apr 1, 2026
- RETINOID ORPHAN RECEPTOR GAMMA T (RORgT) PROMOTES INFLAMMATORY EOSINOPHILIA BUT IS DISPENSABLE FOR INNATE IMMUNE-MEDIATED COLITIS
A. Torres-Huerta, K. Ruley-Haase, … D. Boone·bioRxiv·Oct 27, 2023
- Diet Modifies Colonic Microbiota and CD4+ T Cell Repertoire to Trigger Flares in a Novel Model of Colitis Induced by IL-23
L. Chen, Z. He, … S. A. Lira·bioRxiv·Feb 19, 2018